Longitudinal Prospective Natural History Study of Retinopathy in Zellweger Spectrum Disorder

Part of paid clinical trials in Rochester, New York.

Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Study ID
NCT06190626
Status
Recruiting

Conditions

  • Zellweger Spectrum Disorder

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

The goal of this observational study is to define the course of the retinal degeneration in a ZSD patient cohort. The objective of this study is to gather information so the investigators can: 1. define the course of the retinal degeneration in a ZSD patient cohort with retinal degeneration 2. define what tests best monitor the progression of the retinal degeneration 3. generate prognostic information about vision loss in ZSD. At each yearly visit, the participants will answer a functional vision questionnaire, have a physical evaluation, blood test, and participate in a variety of vision tests. The investigators will also collect pertinent medical history. Participants will travel to study site. The study will provide financial support for board and travel.

Key Dates

Start date
Dec 18, 2023
Status verified
Jan 2026
Primary completion
Jan 1, 2029
Completion
Jan 1, 2029

Study Design

Enrollment
30 participants (estimated)

Primary Outcome Measure

Number of participants with disease progression [ Time Frame: 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Rochester Medical Center/Flaum Eye InstituteRochesterNew York14642
Alex Levin, MD
Alex Levin (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, NY